Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial
- Gianni, L.
- Mansutti, M.
- Anton, A.
- Calvo, L.
- Bisagni, G.
- Bermejo, B.
- Semiglazov, V.
- Thill, M.
- Chacon, J.I.
- Chan, A.
- Morales, S.
- Alvarez, I.
- Plazaola, A.
- Zambetti, M.
- Redfern, A.D.
- Dittrich, C.
- Dent, R.A.
- Magazzu, D.
- De Fato, R.
- Valagussa, P.
- Tusquets, I.
ISSN: 2374-2445, 2374-2437
Datum der Publikation: 2018
Ausgabe: 4
Nummer: 3
Seiten: 302-308
Art: Artikel